Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1382

Sep 21, 2020

COVID-19 data scandal prompts tweaks to elite journal’s review process

Posted by in category: biotech/medical

After publishing study based on unverified patient data from Surgisphere, a little-known company, The Lancet promises tighter standards.

Sep 21, 2020

Wall-mounted technology detects COVID-19 in the air

Posted by in category: biotech/medical

Kontrol Energy Corporation, a Canadian public Company, has launched BioCloud – an unobtrusive, wall-mounted technology which detects the presence of COVID-19 in the air. This can trigger an alert system giving real time notifications of the pathogen’s presence to facility managers, allowing outbreaks to be contained before they occur.

This represents a game changer in the fight against COVID-19, according to Kontrol. Immediate applications include schools, hospitals, long term care facilities and mass transit vehicles such as planes, trains and buses.

“There is a critical need for technology that can provide us with assurances that the workplaces, schools, healthcare environments and other spaces we physically occupy are safe and free of infectious disease. Today, we have that in BioCloud,” said Paul Ghezzi, Chief Executive Officer of Kontrol. “Our team has been working day and night since the onset of the pandemic to bring this exciting technology to market. It will be an invaluable tool to enhance the existing system of individual testing and contact tracing.”

Sep 21, 2020

The 4 Top Artificial Intelligence Trends For 2021

Posted by in categories: biotech/medical, robotics/AI

Artificial Intelligence (AI) has been a mega-trend in 2020. The current pandemic has only accelerated the relevance and adoption of AI and machine learning. Here we look at some of the top AI trends for 2021.

Sep 21, 2020

Artificial Intelligence Has Become A Tool For Classifying And Ranking People

Posted by in categories: biotech/medical, mobile phones, robotics/AI

Recommending content, powering chatbots, trading stocks, detecting medical conditions, and driving cars. These are only a small handful of the most well-known uses of artificial intelligence, yet there is one that, despite being on the margins for much of AI’s recent history, is now threatening to grow significantly in prominence. This is AI’s ability to classify and rank people, to separate them according to whether they’re “good” or “bad” in relation to certain purposes.

At the moment, Western civilization hasn’t reached the point where AI-based systems are used en masse to categorize us according to whether we’re likely to be “good” employees, “good” customers, “good” dates and “good” citizens. Nonetheless, all available indicators suggest that we’re moving in this direction, and that this is regardless of whether Western nations consciously decide to construct the kinds of social credit system currently being developed by China.

This risk was highlighted at the end of September, when it emerged that an AI-powered system was being used to screen job candidates in the U.K. for the first time. Developed by the U.S.-based HireVue, it harnesses machine learning to evaluate the facial expressions, language and tone of voice of job applicants, who are filmed via smartphone or laptop and quizzed with an identical set of interview questions. HireVue’s platform then filters out the “best” applicants by comparing the 25,000 pieces of data taken from each applicant’s video against those collected from the interviews of existing “model” employees.

Sep 20, 2020

A multibillion-dollar shopping obsession goes mainstream in China

Posted by in categories: biotech/medical, internet

Hu is part of a rising class of creators in China who are racing to get in on live-stream shopping, an emerging form of retail that has grown into an industry worth an estimated $66 billion. Although the trend has been part of Chinese internet culture for years, analysts say the coronavirus pandemic has made it mainstream.


A rising class of creators in China are racing to get in on live-stream shopping, an emerging form of retail that has become an estimated $66 billion industry.

Sep 20, 2020

AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints

Posted by in category: biotech/medical

Experts are concerned that the company has not been more forthcoming about two participants who became seriously ill after getting its experimental vaccine.

Sep 20, 2020

Russia Strikes Deals to Sell Its Coronavirus Vaccine Internationally

Posted by in category: biotech/medical

Moscow is in various stages of talks and has received requests to supply as many as 1.2 billion doses of its vaccine, which is still in the trial phase.

Sep 20, 2020

Experimental coronavirus vaccine is safe and produces immune response

Posted by in category: biotech/medical

Early results from the first COVID-19 vaccine candidate tested in people showed that it triggered an immune response against the virus with no serious side effects.

Sep 20, 2020

Belgium tops 100,000 cases; world nears 1m COVID-19 deaths: Live

Posted by in category: biotech/medical

Belgium logs sharp rise in cases; Australia sees lowest infections in three months; global death toll exceeds 957,000.

Sep 20, 2020

Former NASA Astronaut will be Commander of Axiom’s civilian flight aboard SpaceX’s Crew Dragon

Posted by in categories: biotech/medical, engineering, law, space travel

Featured image source: NASA / spacex

Axiom Space Inc. is a Houston, Texas start-up, founded by Michael Suffredini who served as NASA’s International Space Station (ISS) Program Manager from 2005 to 2015. He was responsible for overseeing ISS transition from assembly to the initiation of commercial operations. Axiom is mostly staffed by NASA ex-employees, including former NASA Administrator Charles Bolden. – “The leadership team also includes world-class, specialized expertise in commercial utilization of microgravity, on-orbit operations, astronaut training, space financing, engineering, space system architecture/design/development, space medicine, marketing, and law,” the company states. Together, they are all working towards the commercialization of space.

Axiom aims to build a space station in low Earth orbit to continue operations once NASA retires the ISS program and moves beyond the orbiting laboratory to focus operations on the lunar surface. The company also offers spaceflights for regular civilians to experience microgravity and amazing views of Earth from ISS. “While making access to Low Earth Orbit global during the remainder of ISS’ lifetime, Axiom is constructing the future platform that will serve as humanity’s permanently growing home, scientific and industrial complex in Low Earth Orbit (LEO) – the cornerstone of human activity in space,” company states on its website.